These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 21949677)
1. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048 [TBL] [Abstract][Full Text] [Related]
3. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. Zhou J; Schmid T; Frank R; Brüne B J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529 [TBL] [Abstract][Full Text] [Related]
4. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva. Pagoulatos D; Pharmakakis N; Lakoumentas J; Assimakopoulou M Mol Vis; 2014; 20():441-57. PubMed ID: 24715760 [TBL] [Abstract][Full Text] [Related]
5. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway. Kataria N; Martinez CA; Kerr B; Zaiter SS; Morgan M; McAlpine SR; Cook KM Cell Physiol Biochem; 2019; 53(3):480-495. PubMed ID: 31486323 [TBL] [Abstract][Full Text] [Related]
6. Immunoexpression patterns for Hypoxia-inducible Factor-1α and von Hippel-Lindau protein, in relation to Hsp90, of human brain tumors. Assimakopoulou M; Androutsopoulou C; Zolota V; Matsoukas J Histol Histopathol; 2016 May; 31(5):535-46. PubMed ID: 26592496 [TBL] [Abstract][Full Text] [Related]
7. COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70. van de Sluis B; Groot AJ; Vermeulen J; van der Wall E; van Diest PJ; Wijmenga C; Klomp LW; Vooijs M PLoS One; 2009 Oct; 4(10):e7332. PubMed ID: 19802386 [TBL] [Abstract][Full Text] [Related]
8. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70. Zhang D; Li J; Costa M; Gao J; Huang C Cancer Res; 2010 Jan; 70(2):813-23. PubMed ID: 20068160 [TBL] [Abstract][Full Text] [Related]
9. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways. Zhao ZX; Li S; Liu LX World J Gastroenterol; 2024 Jun; 30(21):2793-2816. PubMed ID: 38899332 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90. Trisciuoglio D; Gabellini C; Desideri M; Ziparo E; Zupi G; Del Bufalo D PLoS One; 2010 Jul; 5(7):e11772. PubMed ID: 20668552 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma. Gao YH; Li CX; Shen SM; Li H; Chen GQ; Wei Q; Wang LS Biochem Biophys Res Commun; 2013 May; 435(1):46-51. PubMed ID: 23611775 [TBL] [Abstract][Full Text] [Related]
12. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions. Jung YS; Lee SJ; Yoon MH; Ha NC; Park BJ Cell Cycle; 2012 Dec; 11(23):4462-73. PubMed ID: 23159849 [TBL] [Abstract][Full Text] [Related]
16. Spermidine/spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha. Baek JH; Liu YV; McDonald KR; Wesley JB; Zhang H; Semenza GL J Biol Chem; 2007 Nov; 282(46):33358-33366. PubMed ID: 17875644 [TBL] [Abstract][Full Text] [Related]
17. Hemin, an iron-binding porphyrin, inhibits HIF-1α induction through its binding with heat shock protein 90. Lee JM; Lee WH; Kay HY; Kim ES; Moon A; Kim SG Int J Cancer; 2012 Feb; 130(3):716-27. PubMed ID: 21413014 [TBL] [Abstract][Full Text] [Related]
18. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779 [TBL] [Abstract][Full Text] [Related]
19. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. Kawanami D; Mahabeleshwar GH; Lin Z; Atkins GB; Hamik A; Haldar SM; Maemura K; Lamanna JC; Jain MK J Biol Chem; 2009 Jul; 284(31):20522-30. PubMed ID: 19491109 [TBL] [Abstract][Full Text] [Related]
20. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Katschinski DM; Le L; Schindler SG; Thomas T; Voss AK; Wenger RH Cell Physiol Biochem; 2004; 14(4-6):351-60. PubMed ID: 15319539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]